Literature DB >> 1431422

Histocompatibility antigens and natural killer susceptibility.

J Peña1, R Solana.   

Abstract

The central question of the nature of the structure(s) involved in the recognition of targets by natural killer (NK) cells remains unresolved. Although NK-mediated cytotoxicity is not MHC-restricted, it has been suggested that these cells could recognize the targets more effectively in the absence of MHC class I antigens. In this paper we review the contradictory results obtained when studying the NK susceptibility of cell lines which constitutively express different levels of MHC antigens, or which have been induced to express MHC antigens by gene transfection or gamma-interferon treatment. Taken together, the results indicate that MHC antigens play a differential role in NK lysis depending on the nature of the target cells used; MHC class I antigens play a role in the NK resistance of cells from a hematopoietic lineage, but this does not extend to cells from other origins. The data reviewed also support the hypothesis that MHC class I antigens induced NK resistance by interfering with target structures, and that multiple NK molecules are involved in NK-mediated lysis as part of a possible advanced recognition system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431422     DOI: 10.1007/bf02918618

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  45 in total

1.  Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.

Authors:  A Harel-Bellan; A Quillet; C Marchiol; R DeMars; T Tursz; D Fradelizi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Heterogeneity of human natural killer cells in the spleen.

Authors:  T Witte; K Wordelmann; R E Schmidt
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens.

Authors:  G Dennert; C Landon; E M Lord; D W Bahler; J G Frelinger
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

4.  NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.

Authors:  I Algarra; C Ohlén; M Perez; H G Ljunggren; G Klein; F Garrido; K Kärre
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

5.  The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing.

Authors:  W J Storkus; J Alexander; J A Payne; P Cresswell; J R Dawson
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

6.  NK susceptibility varies inversely with target cell class I HLA antigen expression.

Authors:  W J Storkus; D N Howell; R D Salter; J R Dawson; P Cresswell
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

Review 7.  Mechanism of cytotoxicity by natural killer (NK) cells.

Authors:  R B Herberman; C W Reynolds; J R Ortaldo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

8.  Gamma-interferon (IFN-gamma) produced during effector and target interactions renders target cells less susceptible to NK-cell-mediated lysis.

Authors:  A Grönberg; R Kiessling; G Masucci; L A Guevara; E Eriksson; G Klein
Journal:  Int J Cancer       Date:  1983-11-15       Impact factor: 7.396

9.  Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes.

Authors:  A Giuliani-Bonmassar; G Graziani; L Frati; E Bonmassar
Journal:  Int J Tissue React       Date:  1984

10.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

Authors:  A Moretta; G Tambussi; C Bottino; G Tripodi; A Merli; E Ciccone; G Pantaleo; L Moretta
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  1 in total

1.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.